Nanoformulation of CCL21 greatly increases its effectiveness as an immunotherapy for neuroblastoma.
Poelaert BJ, Romanova S, Knoche SM, Olson MT, Sliker BH, Smits K, Dickey BL, Moffitt-Holida AEJ, Goetz BT, Khan N, Smith L, Band H, Mohs AM, Coulter DW, Bronich TK, Solheim JC.
Poelaert BJ, et al. Among authors: romanova s.
J Control Release. 2020 Nov 10;327:266-283. doi: 10.1016/j.jconrel.2020.07.024. Epub 2020 Jul 22.
J Control Release. 2020.
PMID: 32711026
Free PMC article.